The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia

Gang Zheng, Michael B Streiff, Clifford M Takemoto, Jennifer Bynum, Elise Gelwan, Jayesh Jani, Danielle Judge, Thomas Stephen Kickler

Research output: Contribution to journalArticle

Abstract

Heparin-induced thrombocytopenia (HIT) remains diagnostically challenging. Immunoassays including PF4/heparin enzyme-linked immunosorbent assay (ELISA) have high sensitivity but low specificity. Whether the heparin neutralization assay (HNA) improves the diagnostic accuracy of the PF4/heparin ELISA for HIT is uncertain. In this study, to assess its clinical utility and evaluate whether it improves the diagnostic accuracy for HIT, we implemented HNA in conjunction with PF4/heparin ELISA over a 1-year period. A total of 1194 patient samples were submitted to the laboratory for testing from December 2015 to November 2016. Heparin neutralization assay alone is a poor predictor for HIT, but it has high negative predictive value (NPV): Cases with %inhibition <70% are always negative for serotonin release assay. It improves the diagnostic positive predictive value (PPV) of ELISA without compromising sensitivity: ELISA optical density (OD) ≥1.4 alone has a sensitivity of 88% (14/16) and a PPV of 61% (14/23); with HNA %inhibition ≥70%, the sensitivity remains 88% (14/16) and PPV is 82% (14/17). 4Ts score correlates with ELISA OD and predicts HIT; the predictive accuracy of 4Ts score is further improved by HNA. Interestingly, HNA %inhibition of <70% correlates with low 4Ts scores. Based on its high NPV, HNA has the potential to facilitate more timely and accurate HIT diagnosis.

Original languageEnglish (US)
JournalClinical and Applied Thrombosis/Hemostasis
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Thrombocytopenia
Heparin
Enzyme-Linked Immunosorbent Assay
Immunoassay
Serotonin

Keywords

  • 4Ts score
  • heparin neutralization assay
  • heparin-induced thrombocytopenia
  • PF4/heparin ELISA
  • serotonin release assay

ASJC Scopus subject areas

  • Hematology

Cite this

The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia. / Zheng, Gang; Streiff, Michael B; Takemoto, Clifford M; Bynum, Jennifer; Gelwan, Elise; Jani, Jayesh; Judge, Danielle; Kickler, Thomas Stephen.

In: Clinical and Applied Thrombosis/Hemostasis, 01.01.2017.

Research output: Contribution to journalArticle

@article{22369a38c6584e31a9b03da509114773,
title = "The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia",
abstract = "Heparin-induced thrombocytopenia (HIT) remains diagnostically challenging. Immunoassays including PF4/heparin enzyme-linked immunosorbent assay (ELISA) have high sensitivity but low specificity. Whether the heparin neutralization assay (HNA) improves the diagnostic accuracy of the PF4/heparin ELISA for HIT is uncertain. In this study, to assess its clinical utility and evaluate whether it improves the diagnostic accuracy for HIT, we implemented HNA in conjunction with PF4/heparin ELISA over a 1-year period. A total of 1194 patient samples were submitted to the laboratory for testing from December 2015 to November 2016. Heparin neutralization assay alone is a poor predictor for HIT, but it has high negative predictive value (NPV): Cases with {\%}inhibition <70{\%} are always negative for serotonin release assay. It improves the diagnostic positive predictive value (PPV) of ELISA without compromising sensitivity: ELISA optical density (OD) ≥1.4 alone has a sensitivity of 88{\%} (14/16) and a PPV of 61{\%} (14/23); with HNA {\%}inhibition ≥70{\%}, the sensitivity remains 88{\%} (14/16) and PPV is 82{\%} (14/17). 4Ts score correlates with ELISA OD and predicts HIT; the predictive accuracy of 4Ts score is further improved by HNA. Interestingly, HNA {\%}inhibition of <70{\%} correlates with low 4Ts scores. Based on its high NPV, HNA has the potential to facilitate more timely and accurate HIT diagnosis.",
keywords = "4Ts score, heparin neutralization assay, heparin-induced thrombocytopenia, PF4/heparin ELISA, serotonin release assay",
author = "Gang Zheng and Streiff, {Michael B} and Takemoto, {Clifford M} and Jennifer Bynum and Elise Gelwan and Jayesh Jani and Danielle Judge and Kickler, {Thomas Stephen}",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/1076029617721013",
language = "English (US)",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia

AU - Zheng, Gang

AU - Streiff, Michael B

AU - Takemoto, Clifford M

AU - Bynum, Jennifer

AU - Gelwan, Elise

AU - Jani, Jayesh

AU - Judge, Danielle

AU - Kickler, Thomas Stephen

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Heparin-induced thrombocytopenia (HIT) remains diagnostically challenging. Immunoassays including PF4/heparin enzyme-linked immunosorbent assay (ELISA) have high sensitivity but low specificity. Whether the heparin neutralization assay (HNA) improves the diagnostic accuracy of the PF4/heparin ELISA for HIT is uncertain. In this study, to assess its clinical utility and evaluate whether it improves the diagnostic accuracy for HIT, we implemented HNA in conjunction with PF4/heparin ELISA over a 1-year period. A total of 1194 patient samples were submitted to the laboratory for testing from December 2015 to November 2016. Heparin neutralization assay alone is a poor predictor for HIT, but it has high negative predictive value (NPV): Cases with %inhibition <70% are always negative for serotonin release assay. It improves the diagnostic positive predictive value (PPV) of ELISA without compromising sensitivity: ELISA optical density (OD) ≥1.4 alone has a sensitivity of 88% (14/16) and a PPV of 61% (14/23); with HNA %inhibition ≥70%, the sensitivity remains 88% (14/16) and PPV is 82% (14/17). 4Ts score correlates with ELISA OD and predicts HIT; the predictive accuracy of 4Ts score is further improved by HNA. Interestingly, HNA %inhibition of <70% correlates with low 4Ts scores. Based on its high NPV, HNA has the potential to facilitate more timely and accurate HIT diagnosis.

AB - Heparin-induced thrombocytopenia (HIT) remains diagnostically challenging. Immunoassays including PF4/heparin enzyme-linked immunosorbent assay (ELISA) have high sensitivity but low specificity. Whether the heparin neutralization assay (HNA) improves the diagnostic accuracy of the PF4/heparin ELISA for HIT is uncertain. In this study, to assess its clinical utility and evaluate whether it improves the diagnostic accuracy for HIT, we implemented HNA in conjunction with PF4/heparin ELISA over a 1-year period. A total of 1194 patient samples were submitted to the laboratory for testing from December 2015 to November 2016. Heparin neutralization assay alone is a poor predictor for HIT, but it has high negative predictive value (NPV): Cases with %inhibition <70% are always negative for serotonin release assay. It improves the diagnostic positive predictive value (PPV) of ELISA without compromising sensitivity: ELISA optical density (OD) ≥1.4 alone has a sensitivity of 88% (14/16) and a PPV of 61% (14/23); with HNA %inhibition ≥70%, the sensitivity remains 88% (14/16) and PPV is 82% (14/17). 4Ts score correlates with ELISA OD and predicts HIT; the predictive accuracy of 4Ts score is further improved by HNA. Interestingly, HNA %inhibition of <70% correlates with low 4Ts scores. Based on its high NPV, HNA has the potential to facilitate more timely and accurate HIT diagnosis.

KW - 4Ts score

KW - heparin neutralization assay

KW - heparin-induced thrombocytopenia

KW - PF4/heparin ELISA

KW - serotonin release assay

UR - http://www.scopus.com/inward/record.url?scp=85041916775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041916775&partnerID=8YFLogxK

U2 - 10.1177/1076029617721013

DO - 10.1177/1076029617721013

M3 - Article

C2 - 28774196

AN - SCOPUS:85041916775

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

ER -